Biomarker & diagnostics companies at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
25 biomarker & diagnostics companies are at CTAD 2026 — 38 presentations on the program. Most represented: Roche Diagnostics (6 on the program), Circular Genomics (2 on the program), Spear Bio (1 on the program). 10 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–15 of 25 organizations
| Organization | CTAD 2026 Attendance |
|---|---|
Roche Diagnostics Rotkreuz, Switzerland | |
Roche's diagnostics business; makes Elecsys CSF and plasma pTau217 immunoassays used to detect Alzheimer's amyloid pathology. | Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm |
Circular Genomics San Diego, California | ◇Silver Sponsor |
Develops blood tests based on brain-derived circular RNA to detect Alzheimer's disease and predict its progression. | Talk Tue Nov 17 12:08pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm |
Spear Bio Woburn, Massachusetts | ◇Silver Sponsor |
Makes SPEAR ultrasensitive immunoassays, including blood p-tau217 tests and multiplex tau, NfL and GFAP panels for Alzheimer's research. | Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm |
Araclon Biotech Zaragoza, Spain | |
Grifols subsidiary developing blood-based amyloid-beta assays for Alzheimer's diagnosis and ABvac40, an amyloid-beta vaccine. | Poster Wed Nov 18 7:15am–5:30pm |
T Taudia San Carlos, California | |
Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm | |
Lantheus Bedford, Massachusetts | ◆Gold Sponsor |
Radiopharmaceutical company supplying PET imaging agents, including tau and amyloid tracers used in Alzheimer's research and trials. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue |
Neurocode Bellingham, Washington | ◇Silver Sponsor |
CAP/CLIA-certified neurology lab offering blood p-tau217 tests for Alzheimer's and antibody tests for autoimmune neurological diseases. | Poster Wed Nov 18 7:15am–5:30pm |
Quanterix Billerica, Massachusetts | ◇Silver Sponsor |
Makes Simoa ultrasensitive immunoassays and LucentAD blood tests for Alzheimer's biomarkers such as p-tau217, NfL and GFAP. | |
Agilus Neuro St. Louis, Missouri | |
Washington University spin-out making electrochemical biosensors for point-of-care blood tests of Alzheimer's biomarkers. | |
ALZpath Carlsbad, California | |
Develops the p-tau217 antibody and assays used in blood tests for Alzheimer's pathology. | |
Beckman Coulter Brea, California | |
Danaher diagnostics company making automated immunoassay systems, including blood and CSF tests for Alzheimer's biomarkers. | Poster Wed Nov 18 7:15am–5:30pm |
Biognosys Schlieren, Switzerland | |
Swiss proteomics company offering mass-spectrometry services, software and kits for biomarker discovery. | |
C2N Diagnostics St. Louis, Missouri | |
Runs mass-spectrometry blood tests for Alzheimer's pathology, including the PrecivityAD2 test of p-tau217 and amyloid-beta. | |
DiamiR Biosciences Princeton, New Jersey | |
Develops blood tests based on brain-enriched microRNA biomarkers for neurodegenerative diseases. | Poster Wed Nov 18 7:15am–5:30pm |
GC Gate Core Biotechnology Shenzhen, China | |
Instantly find 20 buyers from biomarker & diagnostics companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse CTAD 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction